Tag: FDA
NPA: State Regulators Discuss FDA Inaction on CBD
Washington, D.C.—The Natural Products Association (NPA) reported that, during an NPA webinar on June 23, state regulators "sounded off" on the Food and Drug Administration...
CRN Calls on FDA to Move Forward With CBD
Washington, D.C.—The Council for Responsible Nutrition (CRN) has submitted a Citizen’s Petition to FDA, requesting that the agency establish a regulatory pathway to legally...
AHPA Analyzes COVID-19 Warning Letters
Silver Spring, MD—The American Herbal Products Association (AHPA) has released its analysis of 135 COVID-19 related warning letters that were issued by either the...
CCSS Calls for FDA Action on CBD
Washington, D.C.—The Collaborative for CBD Science and Safety (CCSS)—which provides a forum for industry, researchers, academia, healthcare practitioners, and regulators to exchange information and...
NPA Invites FDA to Brief Industry on CBD Regulatory Process, Progress
Washington, D.C.—The Natural Products Association (NPA) has invited the Food and Drug Administration (FDA) to elaborate on the “substantial progress” FDA said it has...
AFS Guayusa Extract GRAS Dossier Receives “No Comment” From FDA
Austin, TX—Applied Food Sciences (AFS) has presented the GRAS dossier for its AMATEA organic guayusa extract to FDA for review, according to a press...
NPA Urges FDA to Issue Import Alerts
Washington, D.C.—The Natural Products Association (NPA) has urged FDA to issue import alerts for supplements that fail to comply with NDI regulations, according to...
Associations Submit Proposed Framework for NDI Master File
Washington, D.C.—Three trade associations representing the dietary supplements industry have sent a proposed framework for an NDI master file to Steven Tave, the Director...
Biota Biosciences Recalls Unapproved CBD, Curcumin Products
Biota Biosciences is voluntarily recalling several lots of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables to the customer level, according to...
Texas Proposes CBD, Hemp Legislation
Washington, D.C.—Texas has proposed new rules for hemp and cannabidiol (CBD) products, according to a press release from the Natural Products Association (NPA).
The proposal...
